The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Lombart Instrument sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Lombart Instrument Company is a distributor of ophthalmic instruments, services, and supplies. It sells both new and used ophthalmic equipment. The company offers lasers and microscopes, surgical instruments, perimeters and field testing, and ultrasound equipment, among others. It also offers service solutions including instrument repairs, phoropter cleanings, preventative maintenance, reupholstery, technical support, and more. The company has collaborations with Marco Healthcare, Enhanced Medical Services (EMS), Santinelli International, Sios, Innova Medical, Veatch Ophthalmic Instruments, and S4Optik. It operates in California, Colorado, Texas, New Jersey, Missouri, Illinois and others. Lombart is headquartered in Norfolk, Virginia, the US. Key subsidiaries of Lombart Instrument include Innova Medical Ophthalmics and Enhanced Medical Services.
The key metrics of Lombart Instrument related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Lombart Instrument is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Lombart Instrument.
For a detailed understanding of the performance of Lombart Instrument, buy the report here.